Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print First generation antipsychotic drugs as effective as newer ones in some children

First generation antipsychotic drugs as effective as newer ones in some children

September 15, 2008

CHAPEL HILL - Nearly every child who receives an antipsychotic medicine is first prescribed one of the second-generation, or "atypical" drugs, such as olanzapine and risperidone. However, there has never been evidence that these drugs are more effective than the older, first-generation medications.

Now a study from the University of North Carolina at Chapel Hill School of Medicine suggests that molindone, a first-generation drug, is as effective as the newer ones and should be used as a first line of therapy in some children with schizophrenia or schizoaffective disorder.




"People thought the second-generation drugs were superior because they had no side effects. We found that molindone works as well as newer drugs, and in some cases it's safer," said Lin Sikich, M.D., associate professor in the department of psychiatry at UNC and lead author of the study, titled the Treatment of Early-Onset Schizophrenia Spectrum Disorders Study.

"The guidelines are going to have to be rewritten because of this study," Sikich said. A report of the study is published Monday in the Sept. 15, 2008 edition of the American Journal of Psychiatry. Co-author Jeffrey Lieberman, M.D., led the earlier CATIE trial at UNC, a landmark study that compared antipsychotic medications in adults. Lieberman is now at Columbia University Medical Center.

The study is the largest head-to-head trial comparing the newer drugs, which became available in the 1990s, to the older ones, which have been around since the 1950s.

Between 2002 and 2006 the study randomly assigned 119 people aged 8 to 19 years to receive molindone, olanzapine or risperidone over an eight-week period at four sites: UNC; McLean Hospital and Cambridge Health Alliance at Harvard Medical School; Seattle Children's Hospital and the University of Washington; and Case Western Reserve University.

A decline in symptoms was similar across the three medications. But the drugs caused very different types of side effects, Sikich said. Both olanzapine and risperidone were associated with significant weight gain and could put young patients at risk of developing heart disease and diabetes. In fact, the National Institute of Mental Health, which sponsored the study, halted recruitment into the olanzapine arm of the study because of the weight gain problem and the resulting increase in cholesterol and glucose levels.

"Olanzapine should not be a first-line therapy in adolescents," Sikich said.

Both the older "typical" antipsychotics and newer "atypical" ones block dopamine receptors in the brain, but the newer drugs also interact with serotonin receptors and cause fewer muscle side effects, including stiffness, muscle cramps, restlessness and involuntary movements. With some older drugs, the involuntary movements can lead to permanent physical disabilities.

There were more reported cases of restlessness with molindone treatment than with either of the two newer treatments. Participants treated with molindone were also required to receive another drug, benztropine, to decrease muscle cramps and stiffness.

Brandon Constantineau, 18, of Wilmington, N.C., enrolled in the TEOSS study about four years ago. He was initially prescribed olanzapine but quickly began gaining weight, ultimately adding more than 45 pounds over 36 weeks. He was switched to molindone and gained about 8 pounds over the next 31 weeks and saw improvements similar to those with olanzapine. But, probably as a result of being on olanzapine, Sikich said, Brandon developed fatty liver disease and was ultimately prescribed two other medications.

Brandon's case also highlights two other points Sikich makes in the study: the benefits of proper diagnosis and the need for more effective medications.

"He was treated when he was very young, about 3, for ADHD," said Brandon's father, Richard Constantineau. But medications and other therapies didn't help, and Brandon grew violent.

"At the point when we went to see Dr. Sikich, when Brandon was 14, I was getting phone calls from the school because he was making threats against teachers," said Brandon's mother, Darlene Wilson. This coincided with violent threats against his parents and, Brandon said, "at one point in time I thought I was seeing angels with halos and wings, like in the Bible."

A psychiatrist Brandon had been seeing was not helpful, Wilson said, so a pediatrician referred them to Sikich.

Late diagnosis is a common problem with many children who develop early onset schizophrenia or schizoaffective disorder, and the diseases usually develop more severely when they begin in childhood, Sikich said.

Brandon is now doing well on an even newer drug, ziprasidone. But in the TEOSS trial only half of all of the participants responded to any medication.

"Medications make a vast difference in peoples' lives, but we need better treatment options," Sikich said. The trial will next compare outcomes after a one-year course of treatment.

Brandon and his family appreciate first-hand the challenges and advances.

"It's working well for him and we need to enjoy the good times, because it's not always good times," Wilson said. "We just have to enjoy what we have right now."

University of North Carolina School of Medicine



Related Antipsychotic Drugs Current Events and Antipsychotic Drugs News Articles Antipsychotic Drugs Current Events and Antipsychotic Drugs News RSS Antipsychotic Drugs Current Events and Antipsychotic Drugs News RSS
Pitt research identifies new target in brain for treating schizophrenia
Research from the University of Pittsburgh could expand the options for controlling schizophrenia by identifying a brain region that responds to more than one type of antipsychotic drug.

Risks and benefits of antipsychotics in children and adolescents
Many of the psychiatric disorders observed in adults have their onset in childhood or adolescence. In fact some studies show that at least 20% of children and adolescents will fulfil a diagnostic criterion for a mental disorder before reaching adulthood.

Anti-psychotic drug use in the elderly increases despite drug safety warnings
Three regulatory warnings of serious adverse events slowed the growth of use of atypical antipsychotic drugs among elderly patients with dementia, but they did not reduce the overall prescription rate of these drugs.

Looking beyond the drug receptor for clues to drug effectiveness
Antipsychotic drugs that are widely used to treat schizophrenia and other problems may not work as scientists have assumed, according to findings from Duke University Medical Center researchers that could lead to changes in how these drugs are developed and prescribed.

Violence declines with medication use in some with schizophrenia
Some schizophrenia patients become less prone to violence when taking medication, but those with a history of childhood conduct problems continue to pose a higher risk even with treatment, according to a new study by researchers at Duke University Medical Center.

Short-term use of antipsychotics in older adults with dementia linked to serious adverse events
Older adults with dementia who receive short-term courses of antipsychotic medications are more likely to be hospitalized or die than those who do not take the drugs, according to a report in the May 26 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

First do no harm? UH prof taking opposite approach to treat asthma
One month of tough breathing may help asthma sufferers breathe easier in the long run, according to research from one University of Houston professor.

Treatment With An Antipsychotic Drug Found To Cause Changes In Metabolism Earlier Than Expected
Schizophrenia is a complex type of psychotic mental illness characterized by thoughts that are uncoupled from reality.

Restrictive drug policies often cause schizophrenic patients to discontinue medication
Policies requiring authorization before physicians can prescribe newer medications to schizophrenic patients may be counter-productive. According to a new study, patients in Maine's Medicaid program who found themselves in this situation were 29% more likely to stop or disrupt medication use than patients not subject to the policy.

Weight gain induced by antipsychotic drugs can be avoided
A research team from Université Laval's Faculty of Medicine and Robert-Giffard Hospital has demonstrated that weight gain induced by the use of antipsychotic drugs-which in extreme cases can be as high as 30 kilos in only one month-can be avoided through a specially designed weight control program.
More Antipsychotic Drugs Current Events and Antipsychotic Drugs News Articles


Essential Psychopharmacology of Antipsychotics and Mood Stabilizers (Essential Psychopharmacology Series)
by Stephen M. Stahl

Drawn from the best-selling second edition of Essential Psychopharmacology, Steve Stahl has revised and updated the chapters covering antipsychotics and mood stabilizers in this separate volume. This new book covers the many dimensions of psychosis, particularly as associated with schizophrenia, and examines the role of dopamine in psychosis along with the various theories about the causes,...



A Guide to the Extrapyramidal Side Effects of Antipsychotic Drugs
by D. G. Cunningham Owens

Antipsychotic drugs have revolutionized the management of major psychiatric disorders and the outcomes of those who suffer from them. However, they often contribute to a range of adverse effects, among the most frequent and distressing of which are those resulting in disturbance of voluntary motor function. Extrapyramidal side effects--or EPS--are still poorly recognized and frequently...



The Essential Guide to Psychiatric Drugs: Includes The Most Recent Information On: Antidepressants, Tranquilizers and Antianxiety Drugs, Antipsychotics, ... More (Essential Guide to Psychiatric Drugs)
by Jack M. Gorman

Informative, accessible, and easy to use, The Essential Guide to Psychiatric Drugs has become a classic and indispensable resource for the layperson and professional alike. With detailed descriptions of all the psychiatric medications available today, including their uses, side-effects, cost, dosage, and more, consumers can take an active role in their mental health and know what to expect from...

Antipsychotic Drugs, Pharmacodynamics and Pharmacokinetics: Proceedings of the International Symposium Held in Wenner-Gren Center, Stockholm, Septembe ... Library of Science, Technology, Engin)

New antipsychotic drugs: the good, the bad, and the ugly.(Guest Editorial): An article from: Behavioral Health Management
by Alan J. Gelenberg

This digital document is an article from Behavioral Health Management, published by Medquest Communications, LLC on July 1, 2004. The length of the article is 961 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation...

Novel Antipsychotic Drugs
by Herbert Y., ed Meltzer

Gale Encyclopedia of Medicine: Antipsychotic drugs
by Samuel D. Uretsky PharmD

The article is excerpted from Gale Encyclopedia of Medicine. Consult the second edition of this authoritative, comprehensive, in-depth medical guide for information on more than 1,700 medical topics in language accessible to adult laypersons. Presented in a single alphabetical sequence, articles range in length from one or two paragraphs for minor topics, to several pages or more for major...

Gale Encyclopedia of Medicine: Antipsychotic drugs, atypical
by Samuel D. Uretsky PharmD

The article is excerpted from Gale Encyclopedia of Medicine. Consult the second edition of this authoritative, comprehensive, in-depth medical guide for information on more than 1,700 medical topics in language accessible to adult laypersons. Presented in a single alphabetical sequence, articles range in length from one or two paragraphs for minor topics, to several pages or more for major...

Novel Antipsychotic Drugs



Antipsychotic Drugs and Their Side-Effects (Neuroscience Perspectives)

In line with other volumes in the Neuroscience Perspectives Series, this volume covers the background, pharmacology, molecular biology, and biochemistry of antipsychotic drugs, together with an overview assessment of the therapeutic considerations. Over the past 40 years, the effectiveness of conventional neuroleptic agents for psychotic illness has been offset by a wide range of adverse...

© 2008 BrightSurf.com